Rofecoxib was a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Rofecoxib industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Oral Suspension.
Tablet-Form
Market Segment by Product Application
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
Finally, the report provides detailed profile and data information analysis of leading company.
Merck
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Tremeau
Pfizer
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Rofecoxib consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Rofecoxib market by identifying its various subsegments.
3.Focuses on the key global Rofecoxib manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Rofecoxib with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Rofecoxib submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Rofecoxib Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Rofecoxib Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Rofecoxib Segment by Type
2.1.1 Oral Suspension.
2.1.2 Tablet-Form
2.2 Market Analysis by Application
2.2.1 Osteoarthritis
2.2.2 Rheumatoid Arthritis
2.2.3 Juvenile Rheumatoid Arthritis
2.2.4 Acute Pain Conditions
2.2.5 Migraine
2.2.6 Dysmenorrhea
2.3 Global Rofecoxib Market Comparison by Regions (2017-2027)
2.3.1 Global Rofecoxib Market Size (2017-2027)
2.3.2 North America Rofecoxib Status and Prospect (2017-2027)
2.3.3 Europe Rofecoxib Status and Prospect (2017-2027)
2.3.4 Asia-pacific Rofecoxib Status and Prospect (2017-2027)
2.3.5 South America Rofecoxib Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Rofecoxib Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Rofecoxib Industry Impact
2.5.1 Rofecoxib Business Impact Assessment - Covid-19
2.5.2 Market Trends and Rofecoxib Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Rofecoxib Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Rofecoxib Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Rofecoxib Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Rofecoxib Manufacturer Market Share
3.5 Top 10 Rofecoxib Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Rofecoxib Market
3.7 Key Manufacturers Rofecoxib Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Rofecoxib Industry Key Manufacturers
4.1 Merck
4.1.1 Company Details
4.1.2 Merck Rofecoxib Product Introduction, Application and Specification
4.1.3 Merck Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Merck News
4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
4.2.1 Company Details
4.2.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Introduction, Application and Specification
4.2.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD News
4.3 Chengdu Meinkai Chemical Co. LTD
4.3.1 Company Details
4.3.2 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Introduction, Application and Specification
4.3.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Chengdu Meinkai Chemical Co. LTD News
4.4 Wuhan Xinxin Jiali Biotechnology Co. LTD
4.4.1 Company Details
4.4.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Introduction, Application and Specification
4.4.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Wuhan Xinxin Jiali Biotechnology Co. LTD News
4.5 Tremeau
4.5.1 Company Details
4.5.2 Tremeau Rofecoxib Product Introduction, Application and Specification
4.5.3 Tremeau Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Tremeau News
4.6 Pfizer
4.6.1 Company Details
4.6.2 Pfizer Rofecoxib Product Introduction, Application and Specification
4.6.3 Pfizer Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Pfizer News
5 Global Rofecoxib Sales Categorized by Regions
5.1 Global Rofecoxib Revenue, Sales and Market Share by Regions
5.1.1 Global Rofecoxib Sales and Market Share by Regions (2017-2022)
5.1.2 Global Rofecoxib Revenue and Market Share by Regions (2017-2022)
5.2 North America Rofecoxib Sales and Growth Rate (2017-2022)
5.3 Europe Rofecoxib Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Rofecoxib Sales and Growth Rate (2017-2022)
5.5 South America Rofecoxib Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Rofecoxib Sales and Growth Rate (2017-2022)
6 North America Rofecoxib Market Size Categorized by Countries
6.1 North America Rofecoxib Sales, Revenue and Market Share by Countries
6.1.1 North America Rofecoxib Sales (Volume) by Countries (2017-2022)
6.1.2 North America Rofecoxib Revenue by Countries (2017-2022)
6.1.3 United States Rofecoxib Sales and Growth Rate (2017-2022)
6.1.4 Canada Rofecoxib Sales and Growth Rate (2017-2022)
6.1.5 Mexico Rofecoxib Sales and Growth Rate (2017-2022)
6.2 North America Rofecoxib Revenue (Value) by Manufacturers
6.3 North America Rofecoxib Sales and Market Share by Type (2017-2022)
6.4 North America Rofecoxib Sales Market Share by Application (2017-2022)
7 Europe Rofecoxib Market Size Categorized by Countries
7.1 Europe Rofecoxib Sales, Revenue and Market Share by Countries
7.1.1 Europe Rofecoxib Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Rofecoxib Revenue by Countries (2017-2022)
7.1.3 Germany Rofecoxib Sales and Growth Rate (2017-2022)
7.1.4 UK Rofecoxib Sales and Growth Rate (2017-2022)
7.1.5 France Rofecoxib Sales and Growth Rate (2017-2022)
7.1.6 Russia Rofecoxib Sales and Growth Rate (2017-2022)
7.1.7 Italy Rofecoxib Sales and Growth Rate (2017-2022)
7.1.8 Spain Rofecoxib Sales and Growth Rate (2017-2022)
7.2 Europe Rofecoxib Revenue (Value) by Manufacturers
7.3 Europe Rofecoxib Sales and Market Share by Type (2017-2022)
7.4 Europe Rofecoxib Sales Market Share by Application (2017-2022)
8 Asia-Pacific Rofecoxib Market Size Categorized by Countries
8.1 Asia-pacific Rofecoxib Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Rofecoxib Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Rofecoxib Revenue by Countries (2017-2022)
8.1.3 China Rofecoxib Sales and Growth Rate (2017-2022)
8.1.4 South Korea Rofecoxib Sales and Growth Rate (2017-2022)
8.1.5 Japan Rofecoxib Sales and Growth Rate (2017-2022)
8.1.6 Australia Rofecoxib Sales and Growth Rate (2017-2022)
8.1.7 India Rofecoxib Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Rofecoxib Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Rofecoxib Revenue (Value) by Manufacturers
8.3 Asia-pacific Rofecoxib Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Rofecoxib Sales Market Share by Application (2017-2022)
9 South America Rofecoxib Market Size Categorized by Countries
9.1 South America Rofecoxib Sales, Revenue and Market Share by Countries
9.1.1 South America Rofecoxib Sales (Volume) by Countries (2017-2022)
9.1.2 South America Rofecoxib Revenue by Countries (2017-2022)
9.1.3 Brazil Rofecoxib Sales and Growth Rate (2017-2022)
9.2 South America Rofecoxib Sales and Market Share by Type (2017-2022)
9.3 South America Rofecoxib Sales Market Share by Application (2017-2022)
10 Middle East and Africa Rofecoxib Market Size Categorized by Countries
10.1 Middle East and Africa Rofecoxib Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Rofecoxib Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Rofecoxib Revenue by Countries (2017-2022)
10.1.3 GCC Countries Rofecoxib Sales and Growth Rate (2017-2022)
10.1.4 Turkey Rofecoxib Sales and Growth Rate (2017-2022)
10.1.5 Egypt Rofecoxib Sales and Growth Rate (2017-2022)
10.1.6 South America Rofecoxib Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Rofecoxib Sales and Market Share by Type
10.3 Middle East and Africa Rofecoxib Sales Market Share by Application (2017-2022)
11 Global Rofecoxib Market Segment by Type
11.1 Global Rofecoxib Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Rofecoxib Sales and Market Share by Type (2017-2022)
11.1.2 Global Rofecoxib Revenue and Market Share by Type (2017-2022)
11.2 Oral Suspension. Sales Growth Rate and Price
11.2.1 Global Oral Suspension. Sales Growth Rate (2017-2022)
11.2.2 Global Oral Suspension. Price (2017-2022)
11.3 Tablet-Form Sales Growth Rate and Price
11.3.1 Global Tablet-Form Sales Growth Rate (2017-2022)
11.3.2 Global Tablet-Form Price (2017-2022)
12 Global Rofecoxib Market Segment by Application
12.1 Global Rofecoxib Sales Market Share by Application (2017-2022)
12.2 Osteoarthritis Sales Growth Rate (2017-2022)
12.3 Rheumatoid Arthritis Sales Growth Rate (2017-2022)
12.4 Juvenile Rheumatoid Arthritis Sales Growth Rate (2017-2022)
12.5 Acute Pain Conditions Sales Growth Rate (2017-2022)
12.7 Dysmenorrhea Sales Growth Rate (2017-2022)
13 Global Rofecoxib Market Forecast
13.1 Global Rofecoxib Revenue, Sales and Growth Rate (2022-2027)
13.2 Rofecoxib Market Forecast by Regions (2022-2027)
13.2.1 North America Rofecoxib Market Forecast (2022-2027)
13.2.2 Europe Rofecoxib Market Forecast (2022-2027)
13.2.3 Asia-Pacific Rofecoxib Market Forecast (2022-2027)
13.2.4 South America Rofecoxib Market Forecast (2022-2027)
13.2.5 Middle East & Africa Rofecoxib Market Forecast (2022-2027)
13.3 Rofecoxib Market Forecast by Type (2022-2027)
13.3.1 Global Rofecoxib Sales Forecast by Type (2022-2027)
13.3.2 Global Rofecoxib Market Share Forecast by Type (2022-2027)
13.4 Rofecoxib Market Forecast by Application (2022-2027)
13.4.1 Global Rofecoxib Sales Forecast by Application (2022-2027)
13.4.2 Global Rofecoxib Market Share Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Rofecoxib Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Rofecoxib Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Rofecoxib
Figure Market Concentration Ratio and Market Maturity Analysis of Rofecoxib
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Rofecoxib Market Size by Type
Figure Global Market Share of Rofecoxib by Type in 2021
Figure Oral Suspension. Picture
Figure Tablet-Form Picture
Table Global Rofecoxib Market Size (Volume) by Application
Figure Osteoarthritis Picture
Figure Rheumatoid Arthritis Picture
Figure Juvenile Rheumatoid Arthritis Picture
Figure Acute Pain Conditions Picture
Figure Migraine Picture
Figure Dysmenorrhea Picture
Table Global Rofecoxib Comparison by Regions (M USD) 2017-2027
Figure Global Rofecoxib Market Size (Million US$) (2017-2027)
Figure North America Rofecoxib Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Rofecoxib Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Rofecoxib Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Rofecoxib Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Rofecoxib Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Rofecoxib Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Rofecoxib Sales by Manufacturer (2017-2022)
Figure Global Rofecoxib Sales Market Share by Manufacturer in 2021
Table Global Rofecoxib Revenue by Manufacturer (2017-2022)
Figure Global Rofecoxib Revenue Market Share by Manufacturer in 2021
Table Global Rofecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Rofecoxib Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Rofecoxib Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Rofecoxib Market
Table Key Manufacturers Rofecoxib Product Type
Table Mergers & Acquisitions Planning
Table Merck Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Merck
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD 2017-2022
Table Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Main Business
Table Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development
Table Chengdu Meinkai Chemical Co. LTD Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Chengdu Meinkai Chemical Co. LTD
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Chengdu Meinkai Chemical Co. LTD 2017-2022
Table Chengdu Meinkai Chemical Co. LTD Main Business
Table Chengdu Meinkai Chemical Co. LTD Recent Development
Table Wuhan Xinxin Jiali Biotechnology Co. LTD Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Wuhan Xinxin Jiali Biotechnology Co. LTD
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Wuhan Xinxin Jiali Biotechnology Co. LTD 2017-2022
Table Wuhan Xinxin Jiali Biotechnology Co. LTD Main Business
Table Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development
Table Tremeau Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Tremeau
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Tremeau 2017-2022
Table Tremeau Main Business
Table Tremeau Recent Development
Table Pfizer Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Pfizer
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Figure Global Rofecoxib Sales and Growth Rate (2017-2022)
Figure Global Rofecoxib Revenue and Growth Rate (2017-2022)
Table Global Rofecoxib Sales by Regions (2017-2022)
Figure Global Rofecoxib Sales Market Share by Regions in 2021
Table Global Rofecoxib Revenue by Regions (2017-2022)
Figure Global Rofecoxib Revenue Market Share by Regions in 2021
Figure North America Rofecoxib Sales and Growth Rate (2017-2022)
Figure Europe Rofecoxib Sales and Growth Rate (2017-2022)
Figure Asia-pacific Rofecoxib Sales and Growth Rate (2017-2022)
Figure South America Rofecoxib Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Rofecoxib Sales and Growth Rate (2017-2022)
Figure North America Rofecoxib Revenue and Growth Rate (2017-2022)
Table North America Rofecoxib Sales (Volume) by Countries (2017-2022)
Table North America Rofecoxib Sales Market Share by Countries (2017-2022)
Figure North America Rofecoxib Sales Market Share by Countries in 2021
Table North America Rofecoxib Revenue by Countries (2017-2022)
Table North America Rofecoxib Revenue Market Share by Countries (2017-2022)
Figure North America Rofecoxib Revenue Market Share by Countries in 2021
Figure United States Rofecoxib Sales and Growth Rate (2017-2022)
Figure Canada Rofecoxib Sales and Growth Rate (2017-2022)
Figure Mexico Rofecoxib Sales and Growth Rate (2017-2022)
Table North America Rofecoxib Revenue by Manufacturer (2021)
Figure North America Rofecoxib Revenue Market Share by Manufacturer in 2021
Table North America Rofecoxib Sales by Type (2017-2022)
Table North America Rofecoxib Sales Share by Type (2017-2022)
Table North America Rofecoxib Sales by Application (2017-2022)
Table North America Rofecoxib Sales Share by Application (2017-2022)
Figure Europe Rofecoxib Revenue and Growth Rate (2017-2022)
Table Europe Rofecoxib Sales (Volume) by Countries (2017-2022)
Table Europe Rofecoxib Sales Market Share by Countries (2017-2022)
Figure Europe Rofecoxib Sales Market Share by Countries in 2021
Table Europe Rofecoxib Revenue by Countries (2017-2022)
Table Europe Rofecoxib Revenue Market Share by Countries (2017-2022)
Figure Europe Rofecoxib Revenue Market Share by Countries in 2021
Figure Germany Rofecoxib Sales and Growth Rate (2017-2022)
Figure UK Rofecoxib Sales and Growth Rate (2017-2022)
Figure France Rofecoxib Sales and Growth Rate (2017-2022)
Figure Russia Rofecoxib Sales and Growth Rate (2017-2022)
Figure Italy Rofecoxib Sales and Growth Rate (2017-2022)
Figure Spain Rofecoxib Sales and Growth Rate (2017-2022)
Table Europe Rofecoxib Revenue by Manufacturer (2021)
Figure Europe Rofecoxib Revenue Market Share by Manufacturer in 2021
Table Europe Rofecoxib Sales by Type (2017-2022)
Table Europe Rofecoxib Sales Share by Type (2017-2022)
Table Europe Rofecoxib Sales by Application (2017-2022)
Table Europe Rofecoxib Sales Share by Application (2017-2022)
Figure Asia-pacific Rofecoxib Revenue and Growth Rate (2017-2022)
Table Asia-pacific Rofecoxib Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Rofecoxib Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Rofecoxib Sales Market Share by Countries in 2021
Table Asia-pacific Rofecoxib Revenue by Countries (2017-2022)
Table Asia-pacific Rofecoxib Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Rofecoxib Revenue Market Share by Countries in 2021
Figure China Rofecoxib Sales and Growth Rate (2017-2022)
Figure South Korea Rofecoxib Sales and Growth Rate (2017-2022)
Figure Japan Rofecoxib Sales and Growth Rate (2017-2022)
Figure Australia Rofecoxib Sales and Growth Rate (2017-2022)
Figure India Rofecoxib Sales and Growth Rate (2017-2022)
Figure Southeast Asia Rofecoxib Sales and Growth Rate (2017-2022)
Table Asia-pacific Rofecoxib Revenue by Manufacturer (2021)
Figure Asia-pacific Rofecoxib Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Rofecoxib Sales by Type (2017-2022)
Table Asia-pacific Rofecoxib Sales Share by Type (2017-2022)
Table Asia-pacific Rofecoxib Sales by Application (2017-2022)
Table Asia-pacific Rofecoxib Sales Share by Application (2017-2022)
Figure South America Rofecoxib Revenue and Growth Rate (2017-2022)
Table South America Rofecoxib Sales (Volume) by Countries (2017-2022)
Table South America Rofecoxib Sales Market Share by Countries (2017-2022)
Figure South America Rofecoxib Sales Market Share by Countries in 2019
Table South America Rofecoxib Revenue by Countries (2017-2022)
Table South America Rofecoxib Revenue Market Share by Countries (2017-2022)
Figure South America Rofecoxib Revenue Market Share by Countries in 2019
Figure Brazil Rofecoxib Sales and Growth Rate (2017-2022)
Table South America Rofecoxib Sales by Type (2017-2022)
Table South America Rofecoxib Sales Share by Type (2017-2022)
Table South America Rofecoxib Revenue by Type (2017-2022)
Table South America Rofecoxib Revenue Share by Type (2017-2022)
Table South America Rofecoxib Sales by Application (2017-2022)
Table South America Rofecoxib Sales Share by Application (2017-2022)
Figure Middle East and Africa Rofecoxib Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Rofecoxib Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Rofecoxib Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Rofecoxib Sales Market Share by Countries in 2019
Table Middle East and Africa Rofecoxib Revenue by Countries (2017-2022)
Table Middle East and Africa Rofecoxib Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Rofecoxib Revenue Market Share by Countries in 2019
Figure GCC Countries Rofecoxib Sales and Growth Rate (2017-2022)
Figure Turkey Rofecoxib Sales and Growth Rate (2017-2022)
Figure Egypt Rofecoxib Sales and Growth Rate (2017-2022)
Figure South Africa Rofecoxib Sales and Growth Rate (2017-2022)
Table Middle East and Africa Rofecoxib Sales by Type (2017-2022)
Table Middle East and Africa Rofecoxib Sales Share by Type (2017-2022)
Table Middle East and Africa Rofecoxib Revenue by Type (2017-2022)
Table Middle East and Africa Rofecoxib Revenue Share by Type (2017-2022)
Table Middle East and Africa Rofecoxib Sales by Application (2017-2022)
Table Middle East and Africa Rofecoxib Sales Share by Application (2017-2022)
Table Global Rofecoxib Sales by Type (2017-2022)
Table Global Rofecoxib Sales Market Share by Type (2017-2022)
Figure Global Rofecoxib Sales Market Share by Type in 2021
Table Global Rofecoxib Revenue by Type (2017-2022)
Table Global Rofecoxib Revenue Market Share by Type (2017-2022)
Figure Global Rofecoxib Revenue Market Share by Type in 2019
Figure Global Oral Suspension. Sales Growth Rate (2017-2022)
Figure Global Oral Suspension. Price (2017-2022)
Figure Global Tablet-Form Sales Growth Rate (2017-2022)
Figure Global Tablet-Form Price (2017-2022)
Table Global Rofecoxib Sales by Application (2017-2022)
Table Global Rofecoxib Sales Market Share by Application (2017-2022)
Figure Global Rofecoxib Sales Market Share by Application in 2021
Figure Global Osteoarthritis Sales Growth Rate (2017-2022)
Figure Global Rheumatoid Arthritis Sales Growth Rate (2017-2022)
Figure Global Juvenile Rheumatoid Arthritis Sales Growth Rate (2017-2022)
Figure Global Acute Pain Conditions Sales Growth Rate (2017-2022)
Figure Global Migraine Sales Growth Rate (2017-2022)
Figure Global Dysmenorrhea Sales Growth Rate (2017-2022)
Figure Global Rofecoxib Sales and Growth Rate (2022-2027)
Figure Global Rofecoxib Revenue and Growth Rate (2022-2027)
Table Global Rofecoxib Sales Forecast by Regions (2017-2022)
Table Global Rofecoxib Market Share Forecast by Regions (2017-2022)
Figure North America Sales Rofecoxib Market Forecast (2022-2027)
Figure Europe Sales Rofecoxib Market Forecast (2022-2027)
Figure Asia-Pacific Sales Rofecoxib Market Forecast (2022-2027)
Figure South America Sales Rofecoxib Market Forecast (2022-2027)
Figure Middle East & Africa Sales Rofecoxib Market Forecast (2022-2027)
Table Global Rofecoxib Sales Forecast by Type (2022-2027)
Table Global Rofecoxib Market Share Forecast by Type (2022-2027)
Table Global Rofecoxib Sales Forecast by Application (2022-2027)
Table Global Rofecoxib Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rofecoxib
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List
Merck
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Tremeau
Pfizer
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)